NICE says ‘too pricey’ to Celgene’s Abraxane combo for pancreatic cancer

Posted: September 9th, 2014  |  Company/topic: Celgene
Website:
The U.K.'s cost-effectiveness watchdogs are cracking down on expensive cancer treatments yet again. This time the ax is falling on Celgene, which learned today that the National Institute for Health a…

NICE ‘no’ for Celgene’s Abraxane in pancreatic cancer

Posted: September 8th, 2014  |  Company/topic: Celgene
Website:
NICE 'no' for Celgene's Abraxane in pancreatic cancer…

NICE ‘no’ for Celgene’s Abraxane in pancreatic cancer

Posted: September 8th, 2014  |  Company/topic: Celgene
Website:
NICE 'no' for Celgene's Abraxane in pancreatic cancer…

BMS Celgene collaborate on a combination trial

Posted: August 31st, 2014  |  Company/topic: Celgene
Website:
Biospectrum Read more…